These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1381914)

  • 21. Generation of Monoclonal Antibodies against Dengue Virus Type 4 and Identification of Enhancing Epitopes on Envelope Protein.
    Tang CT; Liao MY; Chiu CY; Shen WF; Chiu CY; Cheng PC; Chang GJ; Wu HC
    PLoS One; 2015; 10(8):e0136328. PubMed ID: 26309127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of epitopes on dengue virus envelope protein recognized by monoclonal antibodies and polyclonal human sera by a high throughput assay.
    Lin HE; Tsai WY; Liu IJ; Li PC; Liao MY; Tsai JJ; Wu YC; Lai CY; Lu CH; Huang JH; Chang GJ; Wu HC; Wang WK
    PLoS Negl Trop Dis; 2012 Jan; 6(1):e1447. PubMed ID: 22235356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production and characterization of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins.
    Babas T; Le Grand R; Dormont D; Bahraoui E
    AIDS Res Hum Retroviruses; 1997 Sep; 13(13):1109-19. PubMed ID: 9282816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins.
    Falconar AK
    Arch Virol; 1999; 144(12):2313-30. PubMed ID: 10664386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigenic mapping of the envelope proteins of equine infectious anemia virus: identification of a neutralization domain and a conserved region on glycoprotein 90.
    Hussain KA; Issel CJ; Schnorr KL; Rwambo PM; West M; Montelaro RC
    Arch Virol; 1988; 98(3-4):213-24. PubMed ID: 2450529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy.
    Fong RH; Banik SS; Mattia K; Barnes T; Tucker D; Liss N; Lu K; Selvarajah S; Srinivasan S; Mabila M; Miller A; Muench MO; Michault A; Rucker JB; Paes C; Simmons G; Kahle KM; Doranz BJ
    J Virol; 2014 Dec; 88(24):14364-79. PubMed ID: 25275138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection.
    Sukupolvi-Petty S; Brien JD; Austin SK; Shrestha B; Swayne S; Kahle K; Doranz BJ; Johnson S; Pierson TC; Fremont DH; Diamond MS
    J Virol; 2013 Aug; 87(16):8826-42. PubMed ID: 23785205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a neutralizing epitope within antigenic domain 5 of glycoprotein B of human cytomegalovirus.
    Wiegers AK; Sticht H; Winkler TH; Britt WJ; Mach M
    J Virol; 2015 Jan; 89(1):361-72. PubMed ID: 25320309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A major antigenic domain for the human humoral response to Puumala virus nucleocapsid protein is located at the amino-terminus.
    Elgh F; Lundkvist A; Alexeyev OA; Wadell G; Juto P
    J Virol Methods; 1996 May; 59(1-2):161-72. PubMed ID: 8793844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.
    Lam S; Nyo M; Phuektes P; Yew CW; Tan YJ; Chu JJ
    MAbs; 2015; 7(6):1178-94. PubMed ID: 26305993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of Tula virus antigenic determinants defined by monoclonal antibodies raised against baculovirus-expressed nucleocapsid protein.
    Lundkvist A; Vapalahti O; Plyusnin A; Sjölander KB; Niklasson B; Vaheri A
    Virus Res; 1996 Nov; 45(1):29-44. PubMed ID: 8896239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phage-displayed peptide targeting on the Puumala hantavirus neutralization site.
    Heiskanen T; Lundkvist A; Vaheri A; Lankinen H
    J Virol; 1997 May; 71(5):3879-85. PubMed ID: 9094664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies to the glycoprotein of vesicular stomatitis virus (New Jersey serotype): a method for preliminary mapping of epitopes.
    Bricker BJ; Snyder RM; Fox JW; Volk WA; Wagner RR
    Virology; 1987 Dec; 161(2):533-40. PubMed ID: 2446424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of Puumala virus nucleocapsid protein: identification of B-cell epitopes and domains involved in protective immunity.
    Lundkvist A; Kallio-Kokko H; Sjölander KB; Lankinen H; Niklasson B; Vaheri A; Vapalahti O
    Virology; 1996 Feb; 216(2):397-406. PubMed ID: 8607269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigenic structure of the E2 glycoprotein from transmissible gastroenteritis coronavirus.
    Correa I; Jiménez G; Suñé C; Bullido MJ; Enjuanes L
    Virus Res; 1988 Apr; 10(1):77-93. PubMed ID: 2453977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization.
    Wong JA; Bhat R; Hockman D; Logan M; Chen C; Levin A; Frey SE; Belshe RB; Tyrrell DL; Law JL; Houghton M
    J Virol; 2014 Dec; 88(24):14278-88. PubMed ID: 25275133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial characterization of a Hantavirus isolated from a Clethrionomys glareolus captured in Belgium.
    van der Groen G; Beelaert G; Hoofd G; Leirs H; Verhagen R; Yamanishi H; Tkachenko EA; Ivanov AP
    Acta Virol; 1987 Mar; 31(2):180-4. PubMed ID: 2886029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A neutralizing recombinant human antibody Fab fragment against Puumala hantavirus.
    de Carvalho Nicacio C; Lundkvist A; Sjölander KB; Plyusnin A; Salonen EM; Björling E
    J Med Virol; 2000 Apr; 60(4):446-54. PubMed ID: 10686029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of epitopes for neutralizing monoclonal antibodies to classical swine fever virus E2 and Erns using phage-displayed random peptide library.
    Zhang F; Yu M; Weiland E; Morrissy C; Zhang N; Westbury H; Wang LF
    Arch Virol; 2006 Jan; 151(1):37-54. PubMed ID: 16132176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies.
    Hussain KA; Issel CJ; Schnorr KL; Rwambo PM; Montelaro RC
    J Virol; 1987 Oct; 61(10):2956-61. PubMed ID: 2442410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.